• slidebg1
    Welcome to GeneFirst
    Simple, Affordable and Reliable Molecular Diagnostics
  • slidebg1
    Enter the future
    Selectively detect tumour mutations in circulating DNA
    Precisely detect multiple pathogens in closed-tube multiplex
  • slidebg3
    Welcome to GeneFirst
    Low cost enhancements to standard molecular diagnostics
    Simple to use products that give you more answers sooner and better
    RUO, LDT and approvable products for sale

GeneFirst is developing novel diagnostic methods and kits based on proprietary, robust and sensitive DNA detection technology.

About Us

GeneFirst Ltd is a molecular diagnostics company working predominantly in the fields of infectious disease, cancer diagnostics and personalised medicine. GeneFirst offers robust easy-to-use, sensitive, and affordable molecular diagnostics technologies and products to researchers, clinicians and drug companies to enable accurate diagnosis and the delivery of safe and effective medicines. 
→ Read more

Human papillomavirus (HPV) and Cervical cancer

Cervical cancer is the second most common cancer among women worldwide. Human papillomavirus (HPV) is one of the most common sexually transmitted infections (STI). High-risk genotypes types of HPV cause virtually all instances of cervical cancer.
→ Read more

Cell-free DNA in plasma and Cancer

The release of cell-free DNA into the bloodstream of patients with various types of cancer, known as circulating tumour DNA (ctDNA), provides a “liquid biopsy” that appears to relate to the characteristics of the source tumours. Such ctDNA has been used as a non-invasive biomarker to detect malignancy, , gauge prognosis, predict & follow treatment response, and monitor recurrence.
→ Read more

Latest News

Following David Willet’s announcement yesterday (view here), GeneFirst are pleased to confirm that it now holds three TSB awards, two under the Biomedical Catalyst programme, Round 3 Follow-On and Round 5 Feasibility, and one in the Technology Inspired Innovation Competition. Follow the links to get more information.


GeneFirst are currently running two grants, one to clinically validate HPV MPA and the other to analytically validate TBD-Seq.

View Our Publications

View our latest publications
• Polymerase chain displacement reaction (2013)
• Multiplex Detection and SNP Genotyping in a Single Fluorescence Channel (2012)

About us

GeneFirst Ltd is a molecular diagnostics company working predominantly in the fields of infectious disease, cancer diagnostics and personalised medicine.

Latest quote

The science of today is the technology of tomorrow.

Edward Teller

Let GeneFirst technology enable your science of tomorrow!

Contact us

 GeneFirst Ltd, Building E5, Culham Science Centre, Abingdon, Oxfordshire, OX14 3DB UK
 +44 (0) 1865 407400
 info@genefirst.com

Follow us, we are social

Copyright © 2014 GeneFirst Ltd / All rights reserved.